Come up with a name for your new list and we'll add to it:
Pliant Therapeutics raised a round of funding on February 18, 2016. Investors include
Third Rock Ventures.
Pliant Therapeutics is an early-stage biotechnology company harnessing the therapeutic capabilities of integrin biology and TGF-β signaling to develop breakthrough treatments for fibrotic diseases. B…